MON-378 Efficacy and Safety of Romosozumab vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women with Osteoporosis

Postmenopausal women with osteoporosis may also have renal insufficiency. We conducted a post hoc analysis of the ARCH study to determine the efficacy and safety of romosozumab (Romo) vs alendronate (ALN) among patients with different levels of baseline renal function. In ARCH, 4,093 postmenopausal...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Paul, Cheung, Angela M, Reid, Ian, Rojeski, Maria, Vanderkelen, Mark, Yang, Wenjing, Santiago, Norma Ruiz, Oates, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Bone and Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207955/
http://dx.doi.org/10.1210/jendso/bvaa046.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207955/
http://dx.doi.org/10.1210/jendso/bvaa046.050

Ejemplares similares